TM9SF2

Transmembrane 9 superfamily member 2 is a protein that in humans is encoded by the TM9SF2 gene.[5][6]

TM9SF2
Identifiers
Aliases	TM9SF2, P76, transmembrane 9 superfamily member 2
External IDs	OMIM: 604678 MGI: 1915309 HomoloGene: 21004 GeneCards: TM9SF2
Gene location (Human) Chr. Chromosome 13 (human)[1] Band 13q32.3 Start 99,446,311 bp[1] End 99,564,048 bp[1]
Gene location (Mouse) Chr. Chromosome 14 (mouse)[2] Band 14 E5|14 65.86 cM Start 122,107,038 bp[2] End 122,159,604 bp[2]
RNA expression pattern More reference expression data
Orthologs
Species	Human	Mouse
Entrez	9375	68059
Ensembl	ENSG00000125304	ENSMUSG00000025544
UniProt	Q99805	P58021
RefSeq (mRNA)	NM_004800	NM_080556
RefSeq (protein)	NP_004791	NP_542123
Location (UCSC)	Chr 13: 99.45 – 99.56 Mb	Chr 14: 122.11 – 122.16 Mb
PubMed search	[3]	[4]
Wikidata
View/Edit Human View/Edit Mouse

References

1. GRCh38: Ensembl release 89: ENSG00000125304 - Ensembl, May 2017
2. GRCm38: Ensembl release 89: ENSMUSG00000025544 - Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. Schimmoller F, Diaz E, Muhlbauer B, Pfeffer SR (Oct 1998). "Characterization of a 76 kDa endosomal, multispanning membrane protein that is highly conserved throughout evolution". Gene. 216 (2): 311–8. doi:10.1016/S0378-1119(98)00349-7. PMID 9729438.
6. "Entrez Gene: TM9SF2 transmembrane 9 superfamily member 2".

Further reading

• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
• Díaz E, Schimmöller F, Pfeffer SR (1997). "A Novel Rab9 Effector Required for Endosome-to-TGN Transport". J. Cell Biol. 138 (2): 283–90. doi:10.1083/jcb.138.2.283. PMC 2138197. PMID 9230071.
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
• Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
• Dunham A, Matthews LH, Burton J, et al. (2004). "The DNA sequence and analysis of human chromosome 13". Nature. 428 (6982): 522–8. doi:10.1038/nature02379. PMC 2665288. PMID 15057823.
• Colland F, Jacq X, Trouplin V, et al. (2004). "Functional Proteomics Mapping of a Human Signaling Pathway". Genome Res. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.